Alkaloid AD Skopje (XMAE:ALK) Cyclically Adjusted Revenue per Share: MKD11,287.71 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAE:ALK Alkaloid AD Skopje XMAE:ALK
100 GF Score
Price MKD23,300.00
GF Value MKD27,385.06
Valuation Modestly Undervalued
View Full Analysis

What is Alkaloid AD Skopje Cyclically Adjusted Revenue per Share?

Alkaloid AD Skopje XMAE:ALK +1.30% 100 Cyclically Adjusted Revenue per Share is MKD11,287.71 as of Mar. 2026. GuruFocus rates XMAE:ALK with a GF Score™ of 100/100 and a GF Value™ of MKD27,385.06 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Alkaloid AD Skopje's adjusted revenue per share for the three months ended in Mar. 2026 was MKD3,723.962. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MKD11,287.71 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Alkaloid AD Skopje's average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Alkaloid AD Skopje was 10.60% per year. The lowest was 10.10% per year. And the median was 10.35% per year.

As of today (2026-07-19), Alkaloid AD Skopje's current stock price is MKD23300.00. Alkaloid AD Skopje's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MKD11,287.71. Alkaloid AD Skopje's Cyclically Adjusted PS Ratio of today is 2.06.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Alkaloid AD Skopje was 3.14. The lowest was 1.94. And the median was 2.28.


Alkaloid AD Skopje  (XMAE:ALK) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Alkaloid AD Skopje's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=23300.00/11287.71
=2.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Alkaloid AD Skopje was 3.14. The lowest was 1.94. And the median was 2.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Alkaloid AD Skopje Cyclically Adjusted Revenue per Share Related Terms


Alkaloid AD Skopje Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Alkaloid AD Skopje's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkaloid AD Skopje Cyclically Adjusted Revenue per Share Chart

Alkaloid AD Skopje Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,335.99 8,167.77 8,999.05 9,918.85 10,915.73

Alkaloid AD Skopje Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,220.49 10,470.01 10,727.48 10,915.73 11,287.71

XMAE:ALK vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkaloid AD Skopje Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Alkaloid AD Skopje's Cyclically Adjusted PS Ratio falls into.


XMAE:ALK
100GF Score
Alkaloid AD Skopje XMAE:ALK
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkaloid AD Skopje Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alkaloid AD Skopje's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3723.962/330.2130*330.2130
=3,723.962

Current CPI (Mar. 2026) = 330.2130.

Alkaloid AD Skopje Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1,462.567 241.018 2,003.828
201609 1,385.646 241.428 1,895.216
201612 1,505.020 241.432 2,058.456
201703 1,646.372 243.801 2,229.907
201706 1,567.466 244.955 2,113.032
201709 1,476.805 246.819 1,975.781
201712 1,727.646 246.524 2,314.140
201803 1,734.652 249.554 2,295.313
201806 1,644.134 251.989 2,154.516
201809 1,714.263 252.439 2,242.411
201812 1,811.175 251.233 2,380.553
201903 1,999.630 254.202 2,597.556
201906 1,901.548 256.143 2,451.427
201909 1,941.931 256.759 2,497.482
201912 2,011.855 256.974 2,585.245
202003 2,388.594 258.115 3,055.788
202006 1,914.609 257.797 2,452.429
202009 2,030.933 260.280 2,576.612
202012 2,273.405 260.474 2,882.084
202103 2,323.084 264.877 2,896.109
202106 2,128.592 271.696 2,587.041
202109 2,254.703 274.310 2,714.200
202112 2,373.947 278.802 2,811.702
202203 1,913.636 287.504 2,197.908
202206 3,148.045 296.311 3,508.224
202209 2,737.406 296.808 3,045.494
202212 2,347.181 296.797 2,611.447
202303 3,084.880 301.836 3,374.904
202306 2,894.678 305.109 3,132.849
202309 2,880.581 307.789 3,090.446
202312 2,859.505 306.746 3,078.266
202403 3,495.571 312.332 3,695.692
202406 3,229.214 314.175 3,394.059
202409 3,378.923 315.301 3,538.727
202412 3,385.075 315.605 3,541.756
202503 3,691.387 319.799 3,811.594
202506 3,486.207 322.561 3,568.909
202509 3,603.918 324.800 3,663.980
202512 4,051.076 324.054 4,128.071
202603 3,723.962 330.213 3,723.962

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MKD11,287.71 mean?
Alkaloid AD Skopje (XMAE:ALK) has a Cyclically Adjusted Revenue per Share of MKD11,287.71 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alkaloid AD Skopje and its competitors.
Is Alkaloid AD Skopje's Cyclically Adjusted Revenue per Share too high?
Alkaloid AD Skopje's current Cyclically Adjusted Revenue per Share is MKD11,287.71. Overall, Alkaloid AD Skopje has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Alkaloid AD Skopje's Cyclically Adjusted Revenue per Share of MKD11,287.71 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alkaloid AD Skopje and its competitors. Alkaloid AD Skopje's current Cyclically Adjusted Revenue per Share is MKD11,287.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,385.06, compared to a current price of MKD23,300.00 — trading 14.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MKD11,287.71. Alkaloid AD Skopje's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Cyclically Adjusted Revenue per Share is MKD11,287.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued. The current stock price of MKD23,300.00 is trading 14.9% below its estimated GF Value™ of MKD27,385.06. GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.

Key valuation signals for XMAE:ALK:

  • Cyclically Adjusted Revenue per Share: MKD11,287.71
  • GF Value™: MKD27,385.06 vs. price of MKD23,300.00 (14.9% below fair value)
  • GF Score™: 100/100

No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alkaloid AD Skopje Business Description

Address Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
100GF Score

Get the complete analysis for XMAE:ALK

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MKD23,300.00
Price
MKD27,385.06
GF Value